World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), Scope Database, 



Dr. Niranjan S.*, Dr. Debasis Biswal, Dr. Swapna wayamprava, Dr. Subrat Kumar Ojha, Dr. Rajaram Mahto


Amavata (Rheumatoid arthritis) is one of the commonest diseases in the present era which is mainly induced due to improper diet and life style. In the present clinical study 30 Amavata (Rheumatoid arthritis) patients were registered from both OPD and IPD, Dept of Kayachikitsa, Major S.D. Singh PG Ayurvedic Medical College, Farrukkhabad, Uttar Pradesh and were given the medication Rasonadi Kwatha (decoction prepared out of 3 herbal drugs) 30 ml twice daily for duration of 30 days. Aim of the study was to evaluate the efficacy of Rasonadi Kwatha in Amavata. Assessment criteria followed were major clinical symptoms of Amavata and Functional capacity of the joints. Major improvement was seen in 36.67%, Minor improvement in 53.33%, No improvement in 10% and none has recorded complete remission. No untoward incidents or complications were occurred during the treatment period. The trial medication was found to be effective in reducing the symptoms of Amavata (Rheumatoid arthritis).

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here